LeMaitre Vascular, Inc. Revenue 2009–2025
LeMaitre Vascular, Inc. reported $249.60M of revenue for fiscal 2025. That was 13.5% higher than fiscal 2024. Compared with fiscal 2020, the change was +92.9%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $249.60M | +13.5% |
| FY 2024 | $219.86M | +13.6% |
| FY 2023 | $193.48M | +19.7% |
| FY 2022 | $161.65M | +4.7% |
| FY 2021 | $154.42M | +19.4% |
| FY 2020 | $129.37M | +10.4% |
| FY 2019 | $117.23M | +11.0% |
| FY 2018 | $105.57M | +4.7% |
| FY 2017 | $100.87M | +13.1% |
| FY 2016 | $89.15M | +13.8% |
| FY 2015 | $78.35M | +10.2% |
| FY 2014 | $71.10M | +10.1% |
| FY 2013 | $64.55M | +13.8% |
| FY 2012 | $56.73M | -1.6% |
| FY 2011 | $57.69M | +2.9% |
| FY 2010 | $56.06M | +10.1% |
| FY 2009 | $50.91M | — |
Source: LeMaitre Vascular, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open LMAT 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
LeMaitre Vascular, Inc. reported $249.60M of revenue for fiscal 2025. That was 13.5% higher than fiscal 2024. Compared with fiscal 2020, the change was +92.9%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for LeMaitre Vascular, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeLeMaitre Vascular, Inc. — frequently asked questions
What is LeMaitre Vascular, Inc.'s revenue?
LeMaitre Vascular, Inc. (LMAT) reported revenue of $249.60M for fiscal year 2025, per its SEC filings.
How has LeMaitre Vascular, Inc.'s revenue changed over time?
Between fiscal 2009 and 2025, LMAT's revenue grew at roughly 10.4% per year (compound annual rate), from $50.91M to $249.60M.
Where does this data come from?
Figures are computed from LeMaitre Vascular, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.